Covid - treatments rev 12 nov 2022 molnupiravir ↓ paxlovid ↓ remdesevir ↓ other ↓ ......................... molnupiravir: Experts warn Merck's FDA-authorized Covid pill Molnupiravir could 'create breeding ground for mutant viruses' 29 dec 2021 https://www.commondreams.org/news/2021/12/29/experts-warn-mercks-fda-authorized-covid-pill-could-create-breeding-ground-mutant ......................... remdesevir: "FDA is considering approving outpatient remdesivir for the prevention of severe COVID19. Efficacy is excellent, with 81% prevention of hospitalization or death. Like mAbs, this requires IV injection, but remdesivir is easier to synthesize, store, and ship." Source https://www.bloomberg.com/news/articles/2022-01-10/gilead-says-fda-verdict-on-outpatient-remdesivir-could-come-soon Thread with more sources, details, discussion. -- Michael Lin, MD PhD @michaelzlin 13 jan 2022 https://mobile.twitter.com/michaelzlin/status/1481343543398449158 ......................... paxlovid: * Paxlovid update: Effectiveness, rebounding, drug interactions -- Katelyn Jetelina https://yourlocalepidemiologist.substack.com/p/paxlovid-update-effectiveness-rebounding [pub 7 oct 2022] * "Paxlovid was prescribed to me during reinfection.. I took on about day 8 of symptoms due to lack of availability in Jan. ..Yes, it was out of the use within the 3-5 day recommended guideline. IT STILL WORKED FOR ME & HELPED ME GET RELIEF IN Long Covid SYMPTOMS TOO!!" Thread: Anecdotal discussion of antivirals. -- Lady with Long Covid @TheExtraFiles [pub 10 apr 2022] https://mobile.twitter.com/TheExtraFiles/status/1513169977683050500 ....................................................... other: "We certainly need more anti-Covid pills, but a small trial that was stopped early with only 150 patients, claiming >50% reduction of mortality (50% placebo ->20% drug) and fulfilling criteria to get an EUA, seems far-fetched" Link to https://www.nytimes.com/2022/04/11/health/covid-sabizabulin-veru.html -- Eric Topol @EricTopol 12 apr 2022 https://mobile.twitter.com/EricTopol/status/1513715876935061509 _______________________________________________________ begin 27 sep 2021 -- 0 --